Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer screening doesn't significantly reduce death rates and has risks like overdiagnosis and side effects.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

CT scans can find serious prostate cancer even when PSA levels are low.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Higher cholesterol levels increase aggressive prostate cancer risk.

Computational methods help design drugs targeting prostate cancer proteins.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Early baldness in men may indicate a higher risk of prostate cancer.

Early-onset male baldness may indicate a higher risk of prostate cancer.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Male pattern baldness may be linked to prostate cancer risk.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Certain genetic markers may increase or decrease prostate cancer risk.

Certain genetic markers on the Y-chromosome may influence prostate cancer risk in Iraqi males.